Prostate cancer occurs when cancer cells form in tissues of the prostate, a key part of the male reproductive system. This eMedTV article explains the risk factors for prostate cancer and factors that can affect your treatment options and prognosis.
The causes of prostate cancer are still under investigation. However, as this eMedTV article explains, research has identified factors (such as family history) that, while not causes of prostate cancer, may increase the risk of getting the disease.
Prostate cancer symptoms, such as trouble controlling urine flow, may not appear for several years. This eMedTV article discusses prostate cancer symptoms in detail and describes tests used to detect the disease in the absence of symptoms.
Although cancer may be suspected based on other tests, a prostate cancer diagnosis must be made by doing a biopsy. This eMedTV article explains the procedure used to make a prostate cancer diagnosis, including grading, staging, and second opinions.
A PSA test is used to screen for prostate cancer, as well as to monitor recurrence of the disease. This eMedTV article discusses the PSA test in detail, including what the results mean, the test's limitations, and the controversy surrounding it.
On a screening test, a man can have low PSA, and prostate cancer can still be present, although in a clinically insignificant form. This eMedTV article discusses low PSA and prostate cancer in detail and explains recent research findings.
There are five stages of prostate cancer: stages 1 through 4 and recurrent cancer. This eMedTV article discusses the stages of prostate cancer in detail, including the tests used to make the determination.
A Gleason score of 2 to 10 is used to grade whether a prostate tumor is likely to be slow-growing or to metastasize (spread). This eMedTV article explains the process by which a Gleason score is determined.
This eMedTV article discusses both local and systemic forms of prostate cancer treatment. In addition, the pros and cons of prostate cancer treatment, as well a list of questions to ask your doctor, are provided.
A person's prostate cancer prognosis tends to depend more on the stage and grade of the tumor than on the treatment methods. This eMedTV article discusses in detail the prostate cancer prognosis for each stage of the disease.
Is prostate cancer screening right for you? This eMedTV page explains prostate cancer screening methods in detail and presents the risks and benefits. By knowing the pros and cons of screening, men can make the best decisions regarding their health.
Prostate cancer prevention methods discussed in this eMedTV segment include diet, lifestyle, hormonal therapy, and chemoprevention. By engaging in prostate cancer prevention, the chances of developing the disease may decrease.
Prostate cancer research is attempting to determine the cause of the disease as well as new treatment methods. This eMedTV article discusses current areas of prostate cancer research and explains the potential benefits for research participants.
Recent clinical trials suggest a link between prostate cancer chemotherapy and survival. This eMedTV article discusses the background and results of these studies on prostate cancer chemotherapy and survival in detail and explains their limitations.
Prostate cancer statistics, such as those in this eMedTV article, indicate that a man has about a 17 percent chance of being diagnosed with the disease during his lifetime. Other prostate cancer statistics pertain to stage, mortality rates, and more.
To date, there is no definite, verifiable evidence documenting a link between vasectomy and prostate cancer. This eMedTV article explains research studies on vasectomy and prostate cancer, including how testicular cancer may be a greater risk.
| Referring Pages | Articles |
